1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.

Neurocrine Biosciences, Inc.

XNAS: NBIX

Expensive Performer
Download real time

115.71 -1.81 (-1.54%)

26.76% Fall from 52W High

1.3M XNAS Volume

XNAS 09 May, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
14S
8W
5O
0T
2,412.6

Operating Revenue TTM

High in industry
305.8

Net profit TTM

High in industry
12.7

Net Profit Margin TTM %

21.7

Operating Revenue growth TTM %

Below industry Median
-17.3

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
Board Meeting
The next board meeting for Neurocrine Biosciences, Inc. is on 20 May 2025 for the purpose of RBCCM Global Healthcare Conference See details

Neurocrine Biosciences, Inc. quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history